Clinical study on safety assessment of PRP therapy for development dysplasia of hip

Not Applicable

Recruiting

• Conditions: Patients who is diagnosed Hip osteoarthritis (Kellgren and Lawrence grade 4) due to development dysplasia of hip

• Registration Number: JPRN-UMIN000036245
• Lead Sponsor: Juntendo Hospital, Juntendo university school of medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-18
• Study Completion: 2022-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients with a history of hip surgery 2. Patients with abnormal platelet counts in peripheral blood 3.Person who smokes a lot (Brinkmanindex>600) 4. Treatment with anticoagulants(Warfarin) 5. Uncontrolled diabetes mellitus : HbA1c not lower than 9.0% according to latest laboratory data obtained within 14 days before registration 6. Patients with malignancy 7. Patients less than 6 months after onset of cardiac infarction or cerebral infarction 8. Predictive survival period is less than 1 year 9. Active infectious disease (HBV, HCV, HTLV-1, HIV, syphilis) 10.Dialysis patients 11. Compromised host 12.Requiring continued use of oral corticosteroid therapy 13. Less than 20 years old 14.Doctor has determined that it is not suitable for this clinical study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Safety

Secondary Outcome Measures

Name	Time	Method
sefulness